SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-000150
Filing Date
2024-01-09
Accepted
2024-01-09 16:47:09
Documents
13
Period of Report
2024-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k.htm   iXBRL 8-K 30993
2 LICENSE AND DISTRIBUTION AGREEMENT sonoma_ex1001.htm EX-10.1 63316
  Complete submission text file 0001683168-24-000150.txt   282539

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE snoa-20240105.xsd EX-101.SCH 3027
4 XBRL LABEL FILE snoa-20240105_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE snoa-20240105_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3299
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 24523827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)